Patents Examined by Robert Benson
  • Patent number: 4797357
    Abstract: Certain reducible aromatic and quinone compounds having bulky groups on the carbamate nitrogen atom have improved stability to light. These compounds are useful in analytical compositions, elements and methods, e.g. for assays of bacterial cells. These compounds have suitable substituents that promote the release of phenalenone or benzphenalenone fluorescent dyes at physiological pH.
    Type: Grant
    Filed: May 30, 1986
    Date of Patent: January 10, 1989
    Assignee: Eastman Kodak Company
    Inventors: Albert J. Mura, Paul B. Merkel
  • Patent number: 4795702
    Abstract: Method for assay of fragments produced by the reaction between the enzyme immunoglobulin A protease and its substrate immunoglobulin A, sub-class 1. IgA1, IgAP and also bacteria which secrete IgAP may be detected. The assay is especially useful in the detection of Neisseria gonorrhea and in the diagnosis of gonorrhea.
    Type: Grant
    Filed: February 5, 1986
    Date of Patent: January 3, 1989
    Assignee: Immunogon Associates
    Inventor: Milan S. Blake
  • Patent number: 4795715
    Abstract: Derivatives of propranolol which have the following structure: ##STR1## where R is X--(CH.sub.2).sub.n --O, X is NH.sub.2 or COOH, n is 1,2,3,4, or 5, provided that when n is 1, X must be COOH, and R is attached in the 4',5',6',7' or 8' position. The compounds are useful in immunoassay applications to (1) conjugate to a protein carrier in order to prepare antibodies to propranolol and (2) to conjugate to a tracer moiety such as a radiolabeled ligand, an enzyme, an enzyme substrate or a fluorescent dye.
    Type: Grant
    Filed: October 3, 1986
    Date of Patent: January 3, 1989
    Assignee: Drug Science Foundation
    Inventors: Thomas D. Eller, Daniel R. Knapp
  • Patent number: 4794089
    Abstract: A method is disclosed for detecting the occurrence of a binding or complex-forming reaction between specific substances by utilizing the binding reaction to complete an electrical circuit, and then measuring a change in the electrical state of this circuit. In a preferred embodiment, a layer of antigen is coated onto a non-conductive base between a pair of electrically conductive layers superposed on the base. Antibodies which react with the foregoing antigen are treated so that they become bound to fine electrically conductive, metallic particles. The electrically conductive particles having antibody bound thereto are then added to the antigen layer deposited on the base and allowed to react therewith. Electrically conductive particles are thereby bound to the base due to the binding reaction between the antigen and antibody to thereby form aggregates of electrically conductive particles which bridge the electrically conductive layers and complete the circuit.
    Type: Grant
    Filed: March 25, 1986
    Date of Patent: December 27, 1988
    Assignee: Midwest Research Microscopy, Inc.
    Inventors: Susan J. Mroczkowski, Kenneth A. Siegesmund, Donald E. Yorde
  • Patent number: 4794073
    Abstract: A nucleic acid probe capable of participating in a chemiluminescent reaction comprising a defined nucleic acid sequence, the sequence being linked to any one ofa. a chemiluminescence precursor,b. a chemiluminescence enhancer, andc. an enzyme the remaining two of (a), (b) and (c) not linked to the sequence being in a mixture of the linked sequence. A method for determining a particular single stranded polynucleotide sequence in a test medium, comprising the steps of:(a) combining the test medium with a polynucleotide probe having a base sequence substantially complementary to the sequence to be determined,(b) labeling either the resulting hybrids or probe which has not hybridized with the sequence to be determined with one of the participants in an enhanced chamiluminescent reaction involving a chemiluminescent precursor, an enzyme, an oxidant, and a chemiluminescence enhancer,(c) initiating such chemiluminent reaction with the labeled hybrid or probe, and(d) detecting the resulting light emission.
    Type: Grant
    Filed: July 10, 1985
    Date of Patent: December 27, 1988
    Assignee: Molecular Diagnostics, Inc.
    Inventors: Nanibhushan Dattagupta, Anton H. Clemens
  • Patent number: 4791069
    Abstract: Methods for attaching one component of a ligand-anti-ligand pair onto a solid phase surface. The component may be attached to a photoactivatable cross-linker capable of coupling the component to a colloidal medium coating the surface or alternatively, the component may be coupled to a bead and held in place against the surface by an overlay of the colloidal media having voids and spaces smaller than the diameter of the particle but large enough to permit diffusion of the other of the ligand-anti-ligand pair to be detected.
    Type: Grant
    Filed: May 8, 1987
    Date of Patent: December 13, 1988
    Assignee: Ortho Diagnostic Systems Inc.
    Inventors: George Hovorka, W. Peter Hansen
  • Patent number: 4788137
    Abstract: A method of detecting activated T-cells in a population of cells, the method involving determining intracellular calcium ion concentration or intracellular pH in the cells, a calcium ion concentration two-fold or greater above that of resting T-cells, or a pH increase of over 0.2 pH units, indicating activation.
    Type: Grant
    Filed: October 29, 1985
    Date of Patent: November 29, 1988
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Ellis L. Reinherz, Andres Alcover, Michael J. Weiss
  • Patent number: 4784912
    Abstract: Improved fluorescent labels comprise a fluorescent rare earth chelate incorporated into a polymeric particle derived from a loadable latex. The polymer comprises: (a) from about 50 to about 96 weight percent of recurring units derived from a hydrophobic ethylenically unsaturated polymerizable monomer, (b) from about 2 to about 30 weight percent of recurring units derived from a nonionic hydrophilic ethylenically unsaturated polymerizable monomer, and (c) from about 2 to about 20 weight percent of recurring units derived from an anionic ethylenically unsaturated polymerizable monomer containing at least one solubilizing group. The labels of this invention have greatly improved stability in aqueous solutions and do not prematurely agglomerate during storage. They can be attached to any of a variety of physiologically reactive species to provide labeled species, and are particularly useful in specific binding assays.
    Type: Grant
    Filed: October 26, 1987
    Date of Patent: November 15, 1988
    Assignee: Eastman Kodak Company
    Inventors: James R. Schaeffer, Tsang J. Chen, Michael A. Schen
  • Patent number: 4782068
    Abstract: The invention relates to new quinoline derivatives of the formula: ##STR1## wherein R stands for C.sub.2 H.sub.5, C.sub.2 H.sub.4 F, CH.sub.2 --O--CH.sub.2 --CH.sub.2 OH, ##STR2## to a process for their preparation comprising reacting, for 12-24 hours, at 70.degree.-95.degree. C., in dimethylformamide, the 1,4-dihydro- 3-ethoxycarbonyl- 6,8- difluoro-4-oxo-quinoline with an excess of RX (2-5 mol of RX for one mol of quinoline), in the presence of K.sub.2 CO.sub.3 and subsequently hydrolyzing the obtained 3-ester by HCl under reflux conditions and to pharmaceutical compositions comprising at least one 1,4-dihydro- 3-carboxy- 6,8-difluoro- 1-R-4-oxo-quinoline derivative in admixture with a pharmaceutically acceptable diluent or carrier.
    Type: Grant
    Filed: March 4, 1987
    Date of Patent: November 1, 1988
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques
    Inventor: Andre Esanu
  • Patent number: 4777132
    Abstract: The specification discloses a method and apparatus for the assay of salicylate (or a derivative thereof) comprising a conducting body having at a surface thereof an enzyme capable of catalyzing the conversion of salicylate (or a derivative thereof) to a catechol whereby said catechol is subject to direct electrochemical measurement as it oxidizes at said surface to generate a current as a measure of the reaction taking place and thereby of the concentration of salicylate at said surface. The method typically comprises the steps of;(a) treating a liquid sample suspected of containing salicylate or a derivative thereof with an enzyme capable of catalyzing the conversion of salicylate or a derivative thereof into a catechol, and,(b) measuring the concentration of catechol in the treated sample by direct electrochemistry.
    Type: Grant
    Filed: April 3, 1986
    Date of Patent: October 11, 1988
    Assignee: Medisense, Inc.
    Inventors: Monika J. Green, Philip N. B. Gibbs
  • Patent number: 4775631
    Abstract: A method of detecting and localizing nucleic acids on polyamide supports which comprises contacting said supports with a suspension of colloidal metal particles whereupon the metal particles bind to the polyamide support and form a colored background against which the location where nucleic acids are present become visible as lighter spots. The method enables the mere qualitative localization of the nucleic acids and the quantitative determination thereof following art-known procedures.
    Type: Grant
    Filed: July 26, 1985
    Date of Patent: October 4, 1988
    Assignee: Janssen Pharmaceuitica, N.V.
    Inventor: Eric L. J. Saman
  • Patent number: 4774191
    Abstract: Fluorescent antigen conjugates are provided comprising antigens covalently bonded to at least one 2,7-dialiphatic substituted-9-phenyl-6-hydroxy-3H-xanthen-3-one, wherein the 1- and 8-positions are unsubstituted. Also provided are novel fluorescent compounds absorbing at wavelengths in excess of 500 nm, having active functionalities for linking to the antigen. Finally, methods are provided for analyzing antigens in serum, whereby serum interference is avoided.
    Type: Grant
    Filed: February 5, 1986
    Date of Patent: September 27, 1988
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Pyare Khanna, Edwin F. Ullman
  • Patent number: 4772551
    Abstract: A method for producing monoclonal antibodies to a trichothecene mycotoxin which are used in a test kit and method of testing are described. The method for producing the monoclonal antibodies uses repeated administration, preferably subcutaneously of a trichothecene polypeptide to a murine and production of a hybridoma to generate the monoclonal antibodies. Trichothecenes are detected in foods and the like using the test kit and method.
    Type: Grant
    Filed: December 26, 1985
    Date of Patent: September 20, 1988
    Assignee: Neogen Corporation
    Inventors: L. Patrick Hart, James J. Pestka, Elie H. Gendloff
  • Patent number: 4772563
    Abstract: 1,10-phenanthroline-2,9-dicarboxylic acid and novel derivatives thereof such as 4,7-diphenyl-1,10-phenanthroline-2,9-dicarboxylic acid and 4,5,9,14-tetraaza-(1,2,3,4)-dibenzanthracene-3,5-dicarboxylic acid can be coupled to proteins through coupling groups to form conjugates which form higly fluorescent chelates in the presence of lanthanide salts. Derivatives of the above acids reactive toward proteins can be readily manufactured by relatively simple synthetic routes, and are useful in fluorescent immunoassay.
    Type: Grant
    Filed: August 8, 1985
    Date of Patent: September 20, 1988
    Assignee: HSC Research Development Corporation
    Inventors: Ramon A. Evangelista, Alfred Pollak
  • Patent number: 4770992
    Abstract: A method for detection of DNA sequences. In the method, chromatin (comprising protein and DNA) is contacted with a cross-linking agent for the protein of the chromatin to provide a substantially rigid chromatin particle. The DNA of the chromatin particle is then subjected to treatment to cause a separation of the individual DNA strands into single stranded DNA. Preselected sequences of the single stranded DNA are then contacted with a complementary polynucleotide probe specific for the DNA sequence of interest. The polynucleotide probe is marked with a fluorescent label thereby labelling a target sequence of DNA in the chromatin particles. The fluorescently tagged DNA sequences are then detected by subjecting the polynucleotide probe to a suitable light source and detecting the light emitted by the fluorescent label so as to identify the preselected DNA sequence.
    Type: Grant
    Filed: November 27, 1985
    Date of Patent: September 13, 1988
    Inventors: Gerrit J. Van den Engh, Barbara J. Trask
  • Patent number: 4767718
    Abstract: Fluorescent reagents useful as opioid receptor probes. Opioids labeled at the 3 position with fluorescers are useful in various in vivo and in vitro methods for the detection and quantification of receptor sites in tissue cells and subcellular particles.
    Type: Grant
    Filed: June 18, 1984
    Date of Patent: August 30, 1988
    Assignee: Southern Illinois University Foundation
    Inventor: Vera K. Meyers
  • Patent number: 4764618
    Abstract: Novel arginine derivatives represented by the general formula ##STR1## wherein R.sup.1 stands for a naphthalenesulfonyl, a naphthalenecarbonyl, a 1,2,3,4-tetrahydronaphthalenesulfonyl, a 1,2,3,4-tetrahydronaphthalenecarbonyl, a dioxa b-6,7-naphthalenesulfonyl, a dioxa b-6,7-naphthalenecarbonyl, a 1,2,3,4-tetrahydro-8-quinolinesulfonyl, a 1,2,3,4-tetrahydro-8-quinolinecarbonyl, a dibenzofuransulfonyl, a dibenzofurancarbonyl, a fluorenesulfonyl, a fluorenecarbonyl, a dibenzothiophenesulfonyl or a dibenzothiophene, and R.sup.2 stands for a piperidino or a piperazino are disclosed. These arginine derivatives and their pharmaceutically acceptable salts have trypsin-inhibiting activity and useful as a pancreatitis remedy.
    Type: Grant
    Filed: June 19, 1987
    Date of Patent: August 16, 1988
    Assignee: Mitsubishi Chemical Industries Limited
    Inventors: Ryoji Kikumoto, Yoshikuni Tamao, Shinji Tonomura, Akira Maruyama, Shosuke Okamoto, Akiko Okunomiya
  • Patent number: 4760030
    Abstract: A method is disclosed for determining the presence of a member of a specific binding pair ("sbp member") consisting of ligand and its homologous receptor in a sample suspected of containing the sbp member. The method comprises combining in an assay medium the sample and an opaque particle capable of agglutinating in the presence of the sbp member. The opaque particle has a particle size of from about 0.2 to 5.0 microns. Next, the assay medium is irradiated with light having a wavelength of from about 350 to 2000 nm, and the optical density of the assay medium is measured. A change in optical density indicates the presence of the sbp member in the sample. The method has particular application in the determination of an antibody in a sample, particularly an autoantibody, such as, for example, rheumatoid factor.
    Type: Grant
    Filed: September 10, 1984
    Date of Patent: July 26, 1988
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Paulette Peterson, Martin Becker
  • Patent number: 4760017
    Abstract: A novel nucleic acid, arabinonucleic acid, is provided as a probe in nucleic acid assays. The arabinose moiety of the probe can be detected with anti-arabinose antibody-label conjugates.
    Type: Grant
    Filed: December 23, 1985
    Date of Patent: July 26, 1988
    Assignee: E. I. Du Pont de Nemours and Company
    Inventor: Randy M. McCormick
  • Patent number: 4758662
    Abstract: A process for the purification of caffeine which comprises carrying out the following steps in any order;(a) recrystallization of caffeine from an aqueous alkaline solution of caffeine containing a reducing agent and(b) extraction of the caffeine from an aqueous alkaline solution of caffeine with a substantially water-immiscible solvent which is liquid under the conditions of the process.
    Type: Grant
    Filed: February 13, 1987
    Date of Patent: July 19, 1988
    Assignee: Nestec S. A.
    Inventors: Pierre Hirsbrunner, Blaise Pavillard